![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Extranodal Nasal NK/T Cell Lymphoma - 25 Studies Found
Completed |
: Gemcitabine in NK/T Cell Lymphoma : NK/T Cell Lymphoma : 2012-08-06 |
Completed |
: Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma : Extranodal NK/T-cell Lymphoma, Nasal Type : 2012-08-13 : Drug: Radiotherapy followed by chemotherapy Radiotherapy Technique: IMRT Total dose: 50 Gy Per fraction: |
Recruiting |
: Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma : Extranodal NK/T-cell Lymphoma, Nasal Type : 2013-08-03 :
|
Active, not recruiting |
: GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma : Extranodal NK/T-cell Lymphoma, Nasal Type : 2013-11-07 :
|
Terminated |
: Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma : Extranodal NK/T-cell Lymphoma, Nasal Type : 2012-08-13 :
|
Completed |
: Retrospective Analysis of Skin/Soft Tissue Primary NK/T Cell Lymphoma : Extranodal NK/T Cell Lymphoma : 2011-04-21 |
Completed |
: International Extranodal NK/T-cell Lymphoma Project : Extranodal NK/T-cell Lymphoma, Nasal Type : 2015-03-06 |
Active, not recruiting |
: Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma : Nasal Type Extranodal NK/T-Cell Lymphoma : 2015-11-22 :
|
Active, not recruiting |
: Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma : Stage I/II Extranodal NK/T-cell Lymphoma : 2009-11-02 : Other: concomitant chemo-radiotherapy followed by VIDL chemotherapy with risk-based application of autologous stem cell transplantation |
Not yet recruiting |
: Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy :
|